Completed
Nintedanib (BIBF 1120) vs Placebo in Refractory Metastatic Colorectal Cancer (LUME-Colon 1)
NCT02149108
- Conditions
- Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +8 more
- Locations
-
- 1199.52.0108 Boehringer Ingelheim Investigational Site Los Angeles, California, United States
- 1199.52.0105 Boehringer Ingelheim Investigational Site New Haven, Connecticut, United States
- 1199.52.0101 Boehringer Ingelheim Investigational Site Plainville, Connecticut, United States
- 1199.52.0121 Boehringer Ingelheim Investigational Site Arlington Heights, Illinois, United States